slotkoers
Nigerian S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
6
NGN
|
0,00%
|
|
0,00%
|
+14,29%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.401
|
3.330
|
6.056
|
6.935
|
7.419
|
9.057
|
Bedrijfswaarde
1 |
3.932
|
3.282
|
6.236
|
10.592
|
10.070
|
12.386
|
K/w-verhouding
|
4,1
x
|
4,65
x
|
6,28
x
|
6,61
x
|
4,98
x
|
8,36
x
|
Dividendrendement
|
8,16%
|
13%
|
8,55%
|
7,46%
|
6,98%
|
-
|
Marktkapitalisatie/omzet
|
0,28
x
|
0,41
x
|
0,64
x
|
0,58
x
|
0,52
x
|
0,46
x
|
Bedrijfswaarde/omzet
|
0,46
x
|
0,41
x
|
0,66
x
|
0,89
x
|
0,7
x
|
0,63
x
|
Bedrijfswaarde/EBITDA
|
2,74
x
|
2,3
x
|
3,2
x
|
4,71
x
|
9,55
x
|
6,52
x
|
Bedrijfswaarde/FCF
|
18,3
x
|
-6,51
x
|
-19,3
x
|
-3,12
x
|
117
x
|
-20,1
x
|
FCF Yield
|
5,48%
|
-15,4%
|
-5,18%
|
-32,1%
|
0,85%
|
-4,97%
|
Price to Book
|
0,66
x
|
0,57
x
|
0,9
x
|
0,95
x
|
0,9
x
|
1,03
x
|
Aantal aandelen (in duizenden)
|
980.000
|
1.725.235
|
1.725.235
|
1.725.235
|
1.725.235
|
1.725.235
|
Referentieprijs
2 |
2,450
|
1,930
|
3,510
|
4,020
|
4,300
|
5,250
|
Datum van publicatie
|
1/04/19
|
12/05/20
|
29/03/21
|
29/03/22
|
29/03/23
|
2/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
8.552
|
8.080
|
9.390
|
11.902
|
14.328
|
19.695
|
EBITDA
1 |
1.435
|
1.427
|
1.950
|
2.250
|
1.054
|
1.900
|
Bedrijfsresultaat (EBIT)
1 |
1.007
|
959,7
|
1.393
|
1.687
|
497,9
|
1.308
|
Operationele Marge
|
11,78%
|
11,88%
|
14,84%
|
14,17%
|
3,48%
|
6,64%
|
Resultaat voor belastingen (EBT)
1 |
817,9
|
900,9
|
1.248
|
1.460
|
2.084
|
1.520
|
Nettowinst (verlies)
1 |
585,2
|
716,4
|
964,6
|
1.050
|
1.491
|
1.083
|
Nettomarge
|
6,84%
|
8,87%
|
10,27%
|
8,82%
|
10,4%
|
5,5%
|
WPA
2 |
0,5971
|
0,4153
|
0,5591
|
0,6084
|
0,8640
|
0,6278
|
Free Cash Flow
1 |
215,4
|
-504
|
-322,9
|
-3.399
|
85,71
|
-615,5
|
FCF-marge
|
2,52%
|
-6,24%
|
-3,44%
|
-28,56%
|
0,6%
|
-3,13%
|
Kasstroomconversie (ebitda)
|
15,01%
|
-
|
-
|
-
|
8,13%
|
-
|
Kasstroomconversie (nettowinst)
|
36,81%
|
-
|
-
|
-
|
5,75%
|
-
|
Dividend per aandeel
2 |
0,2000
|
0,2500
|
0,3000
|
0,3000
|
0,3000
|
-
|
Datum van publicatie
|
1/04/19
|
12/05/20
|
29/03/21
|
29/03/22
|
29/03/23
|
2/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
1.531
|
-
|
180
|
3.656
|
2.652
|
3.328
|
Nettokaspositie
1 |
-
|
48,1
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
1,067
x
|
-
|
0,0923
x
|
1,625
x
|
2,515
x
|
1,752
x
|
Free Cash Flow
1 |
215
|
-504
|
-323
|
-3.399
|
85,7
|
-615
|
ROE (netto-inkomsten/eigen vermogen)
|
9,92%
|
15,1%
|
14,9%
|
15%
|
19,2%
|
12,7%
|
ROA (netto-inkomsten/totale activa)
|
7,63%
|
6,82%
|
7,3%
|
6,59%
|
1,75%
|
4,26%
|
Totale activa
1 |
7.669
|
10.509
|
13.207
|
15.920
|
85.217
|
25.404
|
Nettoactief per aandeel
2 |
3,690
|
3,400
|
3,910
|
4,210
|
4,780
|
5,090
|
Cashflow per aandeel
2 |
0,2700
|
0,3100
|
2,300
|
1,670
|
1,680
|
1,960
|
Capex
1 |
556
|
1.125
|
324
|
539
|
1.742
|
1.042
|
Capex/omzet
|
6,51%
|
13,93%
|
3,45%
|
4,53%
|
12,16%
|
5,29%
|
Datum van publicatie
|
1/04/19
|
12/05/20
|
29/03/21
|
29/03/22
|
29/03/23
|
2/04/24
|
Gemiddelde koersdoel
6,92
NGN Spread / Gemiddelde doel +15,33% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +14,29% | 7,38 mln. | | +26,08% | 681 mld. | | +21,85% | 556 mld. | | -4,77% | 361 mld. | | +16,97% | 325 mld. | | +5,69% | 285 mld. | | +13,68% | 235 mld. | | +3,65% | 199 mld. | | -11,12% | 189 mld. | | -3,40% | 157 mld. |
Farmaceutische producten - Andere
|